Figure 1.
Time to presentation with thrombocytopenia following the most recent dose of a SARS-CoV-2 vaccine. The graph compares vaccine type (Pfizer-BioNTech [n = 39] and Moderna [n = 37]) in persons without reported preexisting platelet disorders.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.